CSIMarket
 


Strata Skin Sciences, Inc.  (MELA)
Other Ticker:  
 
 

MELA's Revenue Growth by Quarter and Year

Strata Skin Sciences,'s Revenue results by quarter and year




MELA Revenue (in millions $) FY 2018 FY 2017 FY 2016 FY 2015
IV Quarter December - 8.00 8.63 9.87
III Quarter September 7.89 7.48 7.77 8.32
II Quarter June 7.53 8.70 7.74 0.61
I Quarter March 6.47 7.27 7.62 0.08
FY   21.89 31.45 31.76 18.88



MELA Revenue third quarter 2018 Y/Y Growth Comment
Strata Skin Sciences, Inc. reported Revenue growth of 5.51% year on year in the third quarter, to $ 7.89 millions, this is lower than Strata Skin Sciences, Inc.'s recent average Revenue surge of 839.44%.

Looking into third quarter results within Medical Equipment & Supplies industry 87 other companies have achieved higher Revenue growth. While Strata Skin Sciences, Inc.' s Revenue increase of 5.51% ranks overall at the positon no. 2107 in the third quarter.




MELA Revenue ( Y/Y Growth %) 2018
2017 2016 2015
IV Quarter December - -7.3 % -12.56 % 2567.57 %
III Quarter September 5.51 % -3.73 % -6.61 % 3681.82 %
II Quarter June -13.45 % 12.4 % 1168.85 % 165.22 %
I Quarter March -11 % -4.59 % 9425 % -20 %
FY   - -0.98 % 68.22 % -

Financial Statements
Strata Skin Sciences,'s third quarter 2018 Revenue $ 7.89 millions MELA's Income Statement
Strata Skin Sciences,'s third quarter 2017 Revenue $ 7.48 millions Quarterly MELA's Income Statement
New: More MELA's historic Revenue Growth >>


MELA Revenue (Quarter on Quarter Growth %)

2018
2017 2016 2015
IV Quarter December - 6.95 % 11.07 % 18.63 %
III Quarter September 4.81 % -14.02 % 0.39 % 1263.93 %
II Quarter June 16.38 % 19.67 % 1.57 % 662.5 %
I Quarter March -19.13 % -15.76 % -22.8 % -78.38 %
FY (Year on Year)   - -0.98 % 68.22 % -




Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #88
Healthcare Sector #287
Overall #2107

Revenue Y/Y Growth Statistics
High Average Low
9284.24 % 839.44 % -32.24 %
(Mar 31 2016)   (Mar 31 2014)
Revenue third quarter 2018 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #88
Healthcare Sector #287
Overall #2107
Revenue Y/Y Growth Statistics
High Average Low
9284.24 % 839.44 % -32.24 %
(Mar 31 2016)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018

Strata Skin Sciences,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
1262.19 % 102.97 % -78.31 %
(Sep 30 2015)  


MELA's III. Quarter Q/Q Revenue Comment
Strata Skin Sciences, Inc. achieved in the III. Quarter 2018 below company average Revenue growth of 4.81% quarter on quarter, to $ 7.89 millions.

Albeit the III. Quarter 2018 Revenue sequential growth was beneath the ordinary of 102.97 %, it has been still promising sign, as the current expension, transcends the -14.02% rise in the III. Quarter a year ago

Within Medical Equipment & Supplies industry 48 other companies have achieved higher Revenue quarter on quarter growth. While Strata Skin Sciences,'s Revenue growth quarter on quarter, overall rank is 974.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #49
Healthcare Sector #217
Overall #974
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #49
Healthcare Sector #217
Overall #974
Revenue Q/Q Growth Statistics
High Average Low
1262.19 % 102.97 % -78.31 %
(Sep 30 2015)  


MELA's III. Quarter Q/Q Revenue Comment
Strata Skin Sciences, Inc. achieved in the III. Quarter 2018 below company average Revenue growth of 4.81% quarter on quarter, to $ 7.89 millions.

III. Quarter 2018 MELA's performance seem to be paradoxical, albeit below the average rise of 102.97 %, yet it shows absolute recovery measured to the -14.02% in the III. Quarter 2017 Zoe  Wood, a business consultant situated in Boston mentioned.

Within Medical Equipment & Supplies industry 48 other companies have achieved higher Revenue quarter on quarter growth. While Strata Skin Sciences,'s Revenue growth quarter on quarter, overall rank is 974.


Strata Skin Sciences,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
12 Months Ending
(Mar 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Sep 30 2017)
Cumulative Revenue 12 Months Ending $ 30.90 $ 31.71 $ 30.64 $ 31.45 $ 32.09
Y / Y Revenue Growth (TTM) -4.55 % 0.96 % -2.44 % -0.97 % -2.77 %
Year on Year Revenue Growth Overall Ranking # 2516 # 2468 # 2938 # 2805 # 2990
Seqeuential Revenue Change (TTM) -2.55 % 0.83 % -2.56 % -1.98 % -0.89 %
Seq. Revenue Growth (TTM) Overall Ranking # 2780 # 2408 # 3371 # 2564 # 3290




Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2018 Strata Skin Sciences, reported a decrease in Revenue by -4.55% year on year, to $31 millions, compare to the 0.96% growth at Jun 30 2018.

In the Healthcare sector 316 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2468 to 2516.

Revenue TTM Q/Q Growth Statistics
High Average Low
631.04 %
46.75 %
-8.67 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 317
Overall # 2516

Revenue TTM Y/Y Growth Statistics
High Average Low
3634.29 %
503.13 %
-4.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 352
S&P 500 # 2780
Cumulative Revenue growth Comment
For the 12 months ended Sep 30 2018 Strata Skin Sciences, reported a decrease in Revenue by -4.55% year on year, to $31 millions, compare to the 0.96% growth at Jun 30 2018.

In the Healthcare sector 316 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2468 to 2516.

Revenue TTM Q/Q Growth Statistics
High Average Low
631.04 %
46.75 %
-8.67 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 113
Healthcare Sector # 317
Overall # 2516

Revenue TTM Y/Y Growth Statistics
High Average Low
3634.29 %
503.13 %
-4.55 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 113
Sector # 352
S&P 500 # 2780




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MELA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MELA's Competitors
Revenue Growth for Strata Skin Sciences,'s Suppliers
Revenue Growth for MELA's Customers

You may also want to know
MELA's Annual Growth Rates MELA's Profitability Ratios MELA's Asset Turnover Ratio MELA's Dividend Growth
MELA's Roe MELA's Valuation Ratios MELA's Financial Strength Ratios MELA's Dividend Payout Ratio
MELA's Roa MELA's Inventory Turnover Ratio MELA's Growth Rates MELA's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2018
Psychemedics Corp  9.62 %$ 9.623 millions
Onconova Therapeutics, Inc.  9.09 %$ 9.091 millions
Ensign Group, Inc  9.07 %$ 9.069 millions
Glaukos Corp  8.65 %$ 8.651 millions
Orasure Technologies Inc  8.44 %$ 8.439 millions
West Pharmaceutical Services, Inc.  8.41 %$ 8.413 millions
Bristol Myers Squibb Co  8.32 %$ 8.317 millions
Pdl Biopharma, Inc.  8.21 %$ 8.206 millions
Acceleron Pharma Inc  8.10 %$ 8.096 millions
Stryker Corp  7.85 %$ 7.851 millions
Civitas Solutions, Inc.  7.65 %$ 7.654 millions
Boston Scientific Corporation  7.65 %$ 7.651 millions
Immucell Corp  7.42 %$ 7.421 millions
Encompass Health Corp  7.23 %$ 7.232 millions
Haemonetics Corp  7.19 %$ 7.190 millions
Lilly Eli & Co  7.14 %$ 7.139 millions
Bruker Corporation  7.12 %$ 7.117 millions
Inspiremd, Inc.  7.10 %$ 7.103 millions
Fonar Corp  7.09 %$ 7.091 millions
Steris Plc  7.06 %$ 7.065 millions
Petmed Express Inc  7.02 %$ 7.023 millions
Meridian Bioscience Inc  6.85 %$ 6.847 millions
Recro Pharma, Inc.  6.83 %$ 6.831 millions
Obalon Therapeutics Inc  6.68 %$ 6.679 millions
Laboratory Corp Of America Holdings  6.63 %$ 6.632 millions
Natus Medical Inc  6.52 %$ 6.519 millions
Fibrogen Inc  6.44 %$ 6.435 millions
Conmed Corporation  6.41 %$ 6.412 millions
Chemed Corporation  6.40 %$ 6.398 millions
Myriad Genetics Inc  6.36 %$ 6.362 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

WCRS's Profile

Stock Price

WCRS's Financials

Business Description

Fundamentals

Charts & Quotes

WCRS's News

Suppliers

WCRS's Competitors

Customers & Markets

Economic Indicators

WCRS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071